Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related ENDP
RBC Says Stay Away From Mylan, Perrigo; Go Long Teva, Allergan
Benzinga's Top Upgrades
Related FHN
Earnings Scheduled For July 17, 2015
6 Rate-Sensitive Stocks Worth Considering Before FOMC Hikes

Analysts at Cantor Fitzgerald downgraded Endo Health Solutions (NASDAQ: ENDP) from “hold” to “sell.” The target price for Endo Health Solutions is set to $30. Endo Health's shares closed at $35.96 yesterday.

Analysts at Morgan Stanley downgraded First Horizon National (NYSE: FHN) from “overweight” to “neutral.” The target price for First Horizon National is set to $11. First Horizon National's shares closed at $11.25 yesterday.

Analysts at Piper Jaffray downgraded Vera Bradley (NASDAQ: VRA) from “overweight” to “neutral.” The price target for Vera Bradley has been lowered from $32 to $24. Vera Bradley's shares closed at $22.46 yesterday.

Berenberg downgraded Oracle (NASDAQ: ORCL) from “buy” to “sell.” The target price for Oracle has been lowered from $35 to $28. Oracle's shares closed at $34.12 yesterday.

Latest Ratings for ENDP

DateFirmActionFromTo
Jul 2015RBC CapitalUpgradesOutperformTop Pick
Jun 2015Stifel NicolausMaintainsBuy
Jun 2015Raymond JamesInitiates Coverage onMarket Perform

View More Analyst Ratings for ENDP
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (ENDP + FHN)

Get Benzinga's Newsletters